Search Results 21-30 of 12271 for ethambutol

  1. Adalimumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Description. Adalimumab injection is used to treat the symptoms and prevent the progression of active rheumatoid arthritis and ankylosing spondylitis.

  2. Adalimumab-adbm (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-adbm injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis and ankylosing spondylitis. It is ...

  3. Hemin (intravenous route) - Mayo Clinic

    Hemin injection is used to reduce the repeated attacks of porphyria (blood disorder) in some women during their menstrual periods after other treatments (eg, ...

  4. Phenobarbital (intravenous route) - Mayo Clinic

    Phenobarbital injection is used to treat seizures in babies. Phenobarbital belongs to the group of medicines called barbiturates. Barbiturates act in the ...

  5. Lefamulin (intravenous route) - Mayo Clinic

    Description. Lefamulin injection is used to treat community-acquired bacterial pneumonia (CABP). Lefamulin belongs to the class of medicines known as ...

  6. Non-Hodgkin's Lymphoma Clinical Trials - Mayo Clinic Research

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  7. Repotrectinib (oral route) - Side effects & dosage - Mayo Clinic

    Repotrectinib is used to treat ROS1-positive non-small cell lung cancer (NSCLC) that has spread within your chest or to other parts of the body. Your doctor ...

  8. Bicalutamide (oral route) - Mayo Clinic

    Bicalutamide is used together with a luteinizing hormone releasing hormone (LHRH) analog (eg, goserelin or leuprolide) to treat stage D2 metastatic prostate ...

  9. Everolimus And Brentuximab Vedotin In Treating Patients With Relapsed Or Refractory Hodgkin Lymphoma - Mayo Clinic

    Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Brentuximab vedotin may interfere with the ability of ...

  10. Phase 1 Trial To Evaluate The Safety, Pharmacokinetics And Pharmacodynamics Of Splicing Modulator H3B-8800 For Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, And Chronic Myelomonocytic Leukemia - Mayo Clinic

    ... ethambutol, chloramphenicol, linezolid, erythromycin, streptomycin, and zidovudine. ... Prior exposure to cisplatin, 5-fluorouracil, tamoxifen, and/or MEK ...